Treatment with VSV-SB-HCC1,2,3 alone was not significantly different from Early anti-PD-L1 + Late VSV-SB-HCC1,2,3, although one mouse in this experiment succumbed to tumor (Fig. 7F, black line). The gene discussed is CD274; the disease is neoplasm.